CR 2345
Latest Information Update: 25 Feb 2010
At a glance
- Originator Rottapharm
- Class Antibacterials; Antiulcers; Gastric antisecretories
- Mechanism of Action Cholecystokinin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastric ulcer
Most Recent Events
- 07 Aug 2003 Preclinical trials in Gastric ulcer in Italy (unspecified route)